Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
- PMID: 32239591
- PMCID: PMC7228333
- DOI: 10.1111/liv.14449
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
Abstract
Background & aims: Coronavirus disease 2019 (COVID-19) has raised world concern for global epidemic since December, 2019. Limited data are available for liver function in COVID-19 patients. We aimed to investigate the risk factors related to liver injury in the COVID-19 patients.
Methods: A retrospective study was performed in non-ICU Ward at Jinyintan Hospital from February 2, 2020 to February 23, 2020. Consecutively confirmed COVID-19 discharged cases were enrolled. The clinical characteristics of patients with liver injury and without liver injury were compared.
Results: A total of 79 COVID-19 patients were included. 31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of alanine transaminase (ALT), aspartate aminotransferase (AST) and bilirubin respectively. Median value of ALT, AST and bilirubin for entire cohort was 36.5 (17.5 ~ 71.5) U/L, 34.5 (25.3 ~ 55.3) U/L and 12.7 (8.1 ~ 15.4) mmol/L respectively. There were no significant differences in age, previous medical history and symptoms between the two groups. Males were more likely to have liver injury when infected with COVID-19 (P < .05); compared with patients without liver injury, patients with liver injury had increased levels of white blood cell counts, neutrophils, CRP and CT score (P < .05) and had a longer length of stay (P < .05). Logistic regression analyses suggested that the extent of pulmonary lesions on CT was a predictor of liver function damage (P < .05).
Conclusions: Liver injury is common in non-ICU hospitalized COVID-19 patients. It may be related to systemic inflammation. Intense monitoring and evaluation of liver function in patients with severe pulmonary imaging lesions should be considered.
Keywords: COVID-19; liver injury; pulmonary lesions; systemic inflammation.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors disclose no conflicts of interest.
Comment in
-
Potential implications of COVID-19 in non-alcoholic fatty liver disease.Liver Int. 2020 Oct;40(10):2568. doi: 10.1111/liv.14484. Epub 2020 May 25. Liver Int. 2020. PMID: 32306495 Free PMC article. No abstract available.
-
Liver injury in COVID-19: Diagnosis and associated factors.Liver Int. 2020 Aug;40(8):2040-2041. doi: 10.1111/liv.14501. Epub 2020 May 14. Liver Int. 2020. PMID: 32359220 Free PMC article. No abstract available.
-
Letter: Liver injury in COVID-19: Diagnosis and associated factors-Authors' reply.Liver Int. 2020 Aug;40(8):2041. doi: 10.1111/liv.14511. Epub 2020 Jun 10. Liver Int. 2020. PMID: 32391936 Free PMC article. No abstract available.
-
Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease.Liver Int. 2020 Oct;40(10):2569-2570. doi: 10.1111/liv.14564. Epub 2020 Jul 5. Liver Int. 2020. PMID: 32558065 Free PMC article. No abstract available.
References
-
- World Health Organization . Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. https://www.who.int/publications‐detail/clinical‐managementof‐severe‐acu.... Accessed 13 March, 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous